What is the Share Price of Ishita Drugs & Industries Ltd?
- Answer Field
-
The share price of Ishita Drugs & Industries Ltd for NSE is ₹ 0.00 and for BSE is ₹ 74.20.
BAJAJ BROKING
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
As of the latest trading session, ISHITA DRUGS & INDUSTRIES LTD. share price is currently at ₹ 74.2, which is down by ₹ -0.55 from its previous closing. Today, the stock has fluctuated between ₹ 74.20 and ₹ 77.00. Over the past year, ISHITA DRUGS & INDUSTRIES LTD. has achieved a return of 12.89 %. In the last month alone, the return has been -6.69 %. Read More...
Particulars | DEC 2024 (Values in Cr) |
---|---|
Revenue | 4.13 |
Operating Expense | 3.88 |
Net Profit | 0.24 |
Net Profit Margin (%) | 5.81 |
Earnings Per Share (EPS) | 0.80 |
EBITDA | 0.37 |
Effective Tax Rate (%) | 25.00 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 37.02 | 19.90 | 2.02 | 283.70 | 34.11 / 77.70 |
BLISS GVS PHARMA LTD | 118.70 | 14.84 | 1.19 | 1250.75 | 92.25 / 184.95 |
CIPLA LTD | 1519.45 | 23.28 | 3.93 | 122716.92 | 1310.05 / 1702.00 |
FERMENTA BIOTECH LIMITED | 266.40 | 22.07 | 2.70 | 784.04 | 145.00 / 449.00 |
GLAXOSMITHKLINE PHARMA LT | 2790.15 | 55.34 | 28.25 | 47266.82 | 1924.30 / 3147.45 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 37.02 | 22.30 | 6.29 | 283.70 | 34.11 / 77.70 |
AMRUTAJAN HEALTH LTD | 709.90 | 41.61 | 6.89 | 2052.37 | 548.05 / 861.40 |
ASTRAZENECA PHARMA IND LT | 8183.35 | 122.05 | 30.11 | 20458.38 | 5180.60 / 9199.00 |
BLISS GVS PHARMA LTD | 118.70 | 15.42 | 1.22 | 1250.75 | 92.25 / 184.95 |
Ishita Drugs & Industries Limited was incorporated in Feb.'92 by Jagdish Agarwal. The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and excipient. It has a state-of-art manufacturing facility, in terms of reaction capabilities, quality control and environmental safety. The plant has been designed and constructed to meet GMP norms.
The genesis of the Ishita Group in 1992 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal, who set up a reactive dye manufacturing unit in Ahmedabad. Buoyed by the growth of its first Venture, the Group made its maiden foray in the pharma sector in 1981 by setting up a small Bulk drugs plant at Surendranagar in Gujarat, to cater to the need of Pharma industry for Quality Products. The Bulk Drugs Industry at that point of time was highly dependent on costly imports and the growth was not achievable. The Company gradually formed a vertically integrated industry chain covering Drug Intermediates, Active Pharma Ingredients (APIs), excipients and finished dosage forms. The Group has 3 manufacturing facilities located in Gujarat, 2 for APIs and drug intermediates (at Ahmedabad and Surendranagar) and 1 for finished pharmaceutical formulations (at Mehsana).
Thereafter, the Company set up a project to manufacture bulk drugs at Sanand, in the Ahmedabad district of Gujarat with an installed capacity of 408 tpa. Commercial production commenced in Jan.'95. It established an in-house R&D laboratory which has developed a highly improved process technology for norfloxacin, which was implemented in the plant during Oct.'95.
The Company in 2009 undertook a small expansion cum-debottlenecking project; it upgraded many existing equipments.
The share price of Ishita Drugs & Industries Ltd for NSE is ₹ 0.00 and for BSE is ₹ 74.20.
The market cap of Ishita Drugs & Industries Ltd for NSE is ₹ 0.00 Cr. and for BSE is ₹ 22.20 Cr. as of now.
The 52 Week High and Low of Ishita Drugs & Industries Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 104.75 and ₹ 56.00.
You can trade in Ishita Drugs & Industries Ltd shares with Bajaj Broking by opening a Demat Account.
The 1 year returns on the stock has been 12.89%.
Ishita Drugs & Industries Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 74.20 as on May 14 2025 12:42 PM.
The market cap of Ishita Drugs & Industries Ltd for NSE ₹ 0.00 & for BSE ₹ 22.20 as on May 14 2025 12:42 PM.
As on May 14 2025 12:42 PM the price-to-earnings (PE) ratio for Ishita Drugs & Industries Ltd share is 25.95.
As on May 14 2025 12:42 PM, the price-to-book (PB) ratio for Ishita Drugs & Industries Ltd share is 34.32.
You can trade in Ishita Drugs & Industries Ltd shares with Bajaj Broking by opening a demat account.
To buy Ishita Drugs & Industries Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Ishita Drugs & Industries Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found